Evidence map›Paper›PMID 36695071›Full record

ArticleJournal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism2023

Amyloid-PET of the white matter: Relationship to free water, fiber integrity, and cognition in patients with dementia and small vessel disease.

Julie Ottoy, Miracle Ozzoude, Katherine Zukotynski, Min Su Kang, Sabrina Adamo, Christopher Scott, Joel Ramirez, Walter Swardfager, Benjamin Lam, Aparna Bhan and 23 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. White matterAlzheimer's research & therapy · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors at 13 institutions in 2 countries.

Julie OttoyLC Campbell Cognitive Neurology Unit, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, University of Toronto, Toronto, ON, Canada.
Miracle OzzoudeLC Campbell Cognitive Neurology Unit, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, University of Toronto, Toronto, ON, Canada.
Katherine ZukotynskiLC Campbell Cognitive Neurology Unit, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, University of Toronto, Toronto, ON, Canada.
Min Su KangLC Campbell Cognitive Neurology Unit, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, University of Toronto, Toronto, ON, Canada.ORCID 0000-0003-0745-6222
Sabrina AdamoLC Campbell Cognitive Neurology Unit, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, University of Toronto, Toronto, ON, Canada.
Christopher ScottLC Campbell Cognitive Neurology Unit, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, University of Toronto, Toronto, ON, Canada.
Joel RamirezLC Campbell Cognitive Neurology Unit, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, University of Toronto, Toronto, ON, Canada.ORCID 0000-0002-5582-1776
Walter SwardfagerDepartment of Pharmacology & Toxicology, University of Toronto, Toronto, ON, Canada.ORCID 0000-0002-0030-8908
Benjamin LamDepartment of Medicine (Division of Neurology), Dr. Sandra Black Centre for Brain Resilience and Recovery, Hurvitz Brain Sciences Research Program, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada.
Aparna BhanLC Campbell Cognitive Neurology Unit, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, University of Toronto, Toronto, ON, Canada.
Parisa MojiriLC Campbell Cognitive Neurology Unit, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, University of Toronto, Toronto, ON, Canada.
Alex KissDepartment of Research Design and Biostatistics, Sunnybrook Research Institute, University of Toronto, Toronto, ON, Canada.
Stephen StrotherDepartment of Medical Biophysics, University of Toronto, Toronto, ON, Canada.
Christian BoctiService de Neurologie, Département de Medicine, Université de Sherbrooke, Sherbrooke, QC, Canada.
Michael BorrieLawson Health Research Institute, Western University, London, ON, Canada.
Howard ChertkowJewish General Hospital and Department of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada.
Richard FrayneDepartments of Radiology and Clinical Neuroscience, Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada.
Robin HsiungPhysics and Astronomy Department and DM Center for Brain Health, University of British Columbia, Vancouver, BC, Canada.
Robert Jr LaforceClinique Interdisciplinaire de Mémoire, Département des Sciences Neurologiques, Université Laval, Québec, QC, Canada.
Michael D NoseworthyDepartments of Medicine and Radiology, McMaster University, Hamilton, ON, Canada.ORCID 0000-0003-1464-159X
Frank S PratoLawson Health Research Institute, Western University, London, ON, Canada.
Demetrios J SahlasDepartment of Medicine, McMaster University, Hamilton, ON, Canada.
Eric E SmithHotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada.
Phillip H KuoDepartment of Medical Imaging, Medicine, and Biomedical Engineering, University of Arizona, Tucson, AZ, USA.
Jordan A ChadDepartment of Medical Biophysics, University of Toronto, Toronto, ON, Canada.
Ofer PasternakDepartments of Psychiatry and Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, USA.
Vesna SossiPhysics and Astronomy Department and DM Center for Brain Health, University of British Columbia, Vancouver, BC, Canada.
Alexander ThielJewish General Hospital and Department of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada.
Jean-Paul SoucyMontreal Neurological Institute, McGill University, Montreal, QC, Canada.
Jean-Claude TardifMontreal Heart Institute, Université de Montréal, Montreal, QC, Canada.
Sandra E BlackLC Campbell Cognitive Neurology Unit, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, University of Toronto, Toronto, ON, Canada.ORCID 0000-0001-7093-8289
Maged GoubranLC Campbell Cognitive Neurology Unit, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, University of Toronto, Toronto, ON, Canada.ORCID 0000-0001-5880-0818
Medical Imaging Trials Network of Canada (MITNEC) and Alzheimer’s Disease Neuroimaging Initiative (ADNI)
Sunnybrook Health Science Centre · CAUniversity of Toronto · CAWestern University · CAJewish General Hospital · CAMcMaster University · CAMontreal Neurological Institute and Hospital · CAUniversity of British Columbia · CAUniversity of Calgary · CABanner - University Medical Center Tucson · USBrigham and Women's Hospital · USMontreal Heart Institute · CAUniversité de Sherbrooke · CAUniversité Laval · CA

Funding

Alzheimer's Disease Neuroimaging Initiative - SupplementU01AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI WEINER, MICHAEL W · 2004 to 2015
$121.0M
NIA NIH HHS U01 AG024904
6 · The paper itself

Abstract

White matter (WM) injury is frequently observed along with dementia. Positron emission tomography with amyloid-ligands (Aβ-PET) recently gained interest for detecting WM injury. Yet, little is understood about the origin of the altered Aβ-PET signal in WM regions. Here, we investigated the relative contributions of diffusion MRI-based microstructural alterations, including free water and tissue-specific properties, to Aβ-PET in WM and to cognition. We included a unique cohort of 115 participants covering the spectrum of low-to-severe white matter hyperintensity (WMH) burden and cognitively normal to dementia. We applied a bi-tensor diffusion-MRI model that differentiates between (i) the extracellular WM compartment (represented via free water), and (ii) the fiber-specific compartment (via free water-adjusted fractional anisotropy [FA]). We observed that, in regions of WMH, a decrease in Aβ-PET related most closely to higher free water and higher WMH volume. In contrast, in normal-appearing WM, an increase in Aβ-PET related more closely to higher cortical Aβ (together with lower free water-adjusted FA). In relation to cognitive impairment, we observed a closer relationship with higher free water than with either free water-adjusted FA or WM PET. Our findings support free water and Aβ-PET as markers of WM abnormalities in patients with mixed dementia, and contribute to a better understanding of processes giving rise to the WM PET signal.

Indexed as

Alzheimer DiseaseDementiaVascular DiseasesWhite MatterCognitionDiffusion Tensor ImagingHumansWaterWaterAlzheimer’s diseaseamyloid-PETdiffusion MRIfree waterwhite matter

Identifiers

PMID36695071
PMCPMC10196746
OpenAlexW4317930664

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.